Changes in the Characteristics of Hepatitis C Patients Treated with Direct-Acting Antivirals from 2014-2016

被引:0
|
作者
Singer, Amanda [1 ]
Matthews, Krystin [2 ]
Osinusi, Anu O. [1 ]
Brainard, Diana [3 ]
Telep, Laura [1 ]
Chokkalingam, Anand [1 ]
机构
[1] Gilead Sci Inc, Foster City, CA 94404 USA
[2] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA
[3] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
621
引用
收藏
页码:369A / 370A
页数:2
相关论文
共 50 条
  • [1] Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C
    Toka, Bilal
    Koksal, Aydin Seref
    Dertli, Ramazan
    Sirin, Goktug
    Fidan, Sami
    Ulger, Yakup
    Harmandar, Ferda
    Yildirim, Abdullah Emre
    Eminler, Ahmet Tarik
    Asil, Mehmet
    Kayar, Yusuf
    Biyik, Murat
    Kuran, Sedef
    Uslan, Mustafa Ihsan
    Hulagu, Sadettin
    DIGESTIVE DISEASES, 2022, : 635 - 643
  • [2] Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
    Egmond, Elfi
    Marino, Zoe
    Navines, Ricard
    Oriolo, Giovanni
    Pla, Anna
    Bartres, Concepcio
    Lens, Sabela
    Forns, Xavier
    Martin-Santos, Rocio
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (01) : 72 - 76
  • [3] Characteristics and care of chronic hepatitis C treated with direct-acting antivirals in migrants
    Doffoel, Michel
    Ernwein, Florence
    Chaffraix, Frederic
    Haumesser, Lucile
    Tripon, Simona
    Bader, Robert
    Lang, Jean-Philippe
    Lang, Anais
    Paya, Dominique
    Royant, Maude
    Velay-Rusch, Aurelie
    Tebacher, Martine
    Meyer, Nicolas
    Habersetzer, Francois
    Baumert, Thomas
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (06) : 664 - 670
  • [4] Changes in the lipid profile in hepatitis C virus infected patients treated with direct-acting antivirals
    Monteserin, L.
    Quinones, R.
    Molina, G.
    Guerra, M.
    Fernandez-Moran, E.
    Jimenez, M.
    Reyes, N.
    Alvarez-Cuenllas, B.
    Linares, P.
    Vivas, S.
    Gutierrez, E.
    Jorquera, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S729 - S729
  • [5] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
    Ioanna Aggeletopoulou
    Christos Konstantakis
    Spilios Manolakopoulos
    Christos Triantos
    World Journal of Gastroenterology, 2017, (24) : 4317 - 4323
  • [6] Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016
    Jung, Jeah
    Du, Ping
    Feldman, Roger
    Kong, Lan
    Riley, Thomas, III
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1236 - 1242
  • [7] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
    Aggeletopoulou, Ioanna
    Konstantakis, Christos
    Manolakopoulos, Spilios
    Triantos, Christos
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (24) : 4317 - 4323
  • [8] Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
    Tufan, Ayse Gokcen
    Hakim, Gozde Dervis
    Akar, Harun
    Akarsu, Mesut
    HEPATOLOGY FORUM, 2020, 1 (02): : 53 - 58
  • [9] Benefits of Direct-Acting Antivirals for Hepatitis C
    Lok, Anna S.
    Chung, Raymond T.
    Vargas, Hugo E.
    Kim, Arthur Y.
    Naggie, Susanna
    Powderly, William G.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (11) : 812 - +
  • [10] Targeting Hepatitis C With Direct-Acting Antivirals
    Pennell, Laurie
    LaPreze, Jennifer
    US PHARMACIST, 2023, 48 (03) : 22 - 27